• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid amides

Professional Introduction to Compound with CAS No. 15059-90-2 and Product Name: 2-Cyano-N-cyclohexyl-N-methylacetamide

Compound with the CAS number 15059-90-2, identified chemically as 2-Cyano-N-cyclohexyl-N-methylacetamide, represents a significant molecule in the realm of pharmaceutical and chemical research. This compound, characterized by its unique structural and functional attributes, has garnered attention due to its potential applications in various biochemical pathways and drug development initiatives. The molecular structure of 2-Cyano-N-cyclohexyl-N-methylacetamide consists of a cyano group attached to a cyclohexyl ring, further substituted with an N-methylacetamide moiety. This configuration imparts distinct reactivity and interaction capabilities, making it a subject of intense study in medicinal chemistry.

The significance of 2-Cyano-N-cyclohexyl-N-methylacetamide is underscored by its role as a key intermediate in synthesizing more complex pharmaceutical agents. Its cyano functionality provides a versatile site for further chemical modifications, enabling the development of derivatives with tailored biological activities. Recent advancements in synthetic methodologies have enhanced the efficiency of producing this compound, facilitating its incorporation into diverse research frameworks. The cyclohexyl group contributes to the compound's lipophilicity, influencing its solubility and bioavailability, which are critical factors in drug formulation and delivery systems.

In the context of contemporary pharmaceutical research, 2-Cyano-N-cyclohexyl-N-methylacetamide has been explored for its potential in modulating enzymatic pathways and interacting with biological targets relevant to therapeutic intervention. Studies have indicated that derivatives of this compound may exhibit inhibitory effects on certain enzymes implicated in inflammatory responses and metabolic disorders. The N-methylacetamide moiety, in particular, has been associated with enhanced binding affinity to specific protein targets, suggesting its utility in designing novel therapeutic agents. These findings align with the broader trend in drug discovery towards identifying small molecules that can selectively interact with disease-causing pathways.

The chemical properties of 2-Cyano-N-cyclohexyl-N-methylacetamide also make it a valuable tool in mechanistic studies aimed at understanding complex biochemical processes. Researchers have leveraged this compound to investigate the dynamics of enzyme-substrate interactions and the structural rearrangements that occur during catalytic reactions. Such insights are crucial for designing drugs that not only target specific pathological processes but also enhance overall metabolic balance. The compound's stability under various reaction conditions further enhances its utility as a reference standard in analytical chemistry and quality control protocols.

Moreover, the synthesis and characterization of 2-Cyano-N-cyclohexyl-N-methylacetamide have contributed to the development of new methodologies in organic chemistry. The integration of catalytic processes and green chemistry principles has enabled more sustainable production methods, reducing waste and energy consumption. These innovations are in line with global efforts to promote environmentally responsible chemical synthesis. The versatility of this compound as a building block for more complex molecules also underscores its importance in library synthesis programs aimed at discovering novel bioactive entities.

The pharmacological potential of derivatives derived from 2-Cyano-N-cyclohexyl-N-methylacetamide continues to be a focal point for interdisciplinary research teams. Collaborative efforts between chemists, biologists, and pharmacologists are yielding promising candidates for preclinical testing. The compound's structural features offer a scaffold for modulating pharmacokinetic properties such as absorption, distribution, metabolism, and excretion (ADME). By fine-tuning these parameters, researchers aim to develop drugs with improved therapeutic profiles and reduced side effects.

Recent publications highlight the role of 2-Cyano-N-cyclohexyl-N-methylacetamide in addressing challenges associated with drug resistance and multifactorial diseases. Its ability to interact with multiple targets within a biological system makes it an attractive candidate for developing combination therapies. Such approaches are particularly relevant in treating complex conditions like cancer and neurodegenerative disorders, where polypharmacology plays a pivotal role. The compound's compatibility with high-throughput screening technologies further accelerates the identification of lead compounds for further development.

The future prospects for 2-Cyano-N-cyclohexyl-N-methylacetamide are bright, given its multifaceted utility across different domains of chemical biology. Ongoing research is expected to uncover additional applications in areas such as agrochemicals and material science, where its unique properties could contribute to innovative solutions. As synthetic capabilities continue to evolve, the accessibility of this compound will likely increase, fostering broader adoption in both academic and industrial settings.

• 15029-30-8(3-oxo-3-(piperidin-1-yl)propanenitrile)
• 479411-64-8(2-Pyrrolidineacetonitrile,1-methyl-5-oxo-,(2R)-(9CI))
• 549474-88-6(Piperidine, 1-(cyanoacetyl)-2,6-dimethyl- (9ci))
• 15029-38-6(2-cyano-N-cyclohexylacetamide)
• 14227-95-3(3-Oxo-3-(pyrrolidin-1-yl)propanenitrile)
• 51838-00-7(Acetamide,2-cyano-N-(3,3,5-trimethylcyclohexyl)-)
• 479411-60-4(2-Pyrrolidineacetonitrile,1-methyl-5-oxo-,(2S)-(9CI))
• 544453-71-6(piperidine,1-(cyanoacetyl)-2-methyl-)
• 549499-13-0(Piperidine,1-(cyanoacetyl)-2-ethyl-(9ci))
• 15112-75-1(2-Cyano-N-cyclopentyl-acetamide)